Global and United States Infantile Spasms Therapeutics Market Research by Company, Type & Application 2013-2025
Summary
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
Market Segment as follows:
By Type
Section 1: Product definition, type and application, global and United States market overview;
Section 2: Global and United States Market competition by company;
Section 3: Global and United States sales revenue, volume and price by type;
Section 4: Global and United States sales revenue, volume and price by application;
Section 5: United States export and import;
Section 6: Company information, business overview, sales data and product specifications;
Section 7: Industry chain and raw materials;
Section 8: SWOT and Porter's Five Forces;
Section 9: Conclusion.
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
Market Segment as follows:
By Type
- Oral
- Injection
- Hospital
- Clinic
- Others
- H. Lundbeck
- Mallinckrodt
- Insys Therapeutics
- Orphelia Pharma
- Valerion Therapeutics
- Catalyst Pharmaceuticals
- Anavex Life Sciences
- Retrophin
Section 1: Product definition, type and application, global and United States market overview;
Section 2: Global and United States Market competition by company;
Section 3: Global and United States sales revenue, volume and price by type;
Section 4: Global and United States sales revenue, volume and price by application;
Section 5: United States export and import;
Section 6: Company information, business overview, sales data and product specifications;
Section 7: Industry chain and raw materials;
Section 8: SWOT and Porter's Five Forces;
Section 9: Conclusion.
1 MARKET OVERVIEW
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Oral
1.1.2.2 Injection
1.1.3 Market by Application
1.1.3.1 Hospital
1.1.3.2 Clinic
1.1.3.3 Others
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 GLOBAL AND REGIONAL MARKET BY COMPANY
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 GLOBAL AND REGIONAL MARKET BY TYPE
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 GLOBAL AND REGIONAL MARKET BY APPLICATION
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 REGIONAL TRADE
5.1 Export
5.2 Import
6 KEY MANUFACTURERS
6.1 H. Lundbeck
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Mallinckrodt
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Insys Therapeutics
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Orphelia Pharma
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Valerion Therapeutics
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Catalyst Pharmaceuticals
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Anavex Life Sciences
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Retrophin
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
7 INDUSTRY UPSTREAM
7.1 Industry Chain
7.2 Raw Materials
8 MARKET ENVIRONMENT
8.1 SWOT
8.2 Porter's Five Forces
9 CONCLUSION
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Oral
1.1.2.2 Injection
1.1.3 Market by Application
1.1.3.1 Hospital
1.1.3.2 Clinic
1.1.3.3 Others
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 GLOBAL AND REGIONAL MARKET BY COMPANY
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 GLOBAL AND REGIONAL MARKET BY TYPE
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 GLOBAL AND REGIONAL MARKET BY APPLICATION
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 REGIONAL TRADE
5.1 Export
5.2 Import
6 KEY MANUFACTURERS
6.1 H. Lundbeck
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Mallinckrodt
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Insys Therapeutics
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Orphelia Pharma
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Valerion Therapeutics
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Catalyst Pharmaceuticals
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Anavex Life Sciences
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Retrophin
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
7 INDUSTRY UPSTREAM
7.1 Industry Chain
7.2 Raw Materials
8 MARKET ENVIRONMENT
8.1 SWOT
8.2 Porter's Five Forces
9 CONCLUSION
LIST OF TABLES
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of H. Lundbeck
Table Sales Revenue, Volume, Price, Cost and Margin of Mallinckrodt
Table Sales Revenue, Volume, Price, Cost and Margin of Insys Therapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of Orphelia Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Valerion Therapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of Catalyst Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Anavex Life Sciences
Table Sales Revenue, Volume, Price, Cost and Margin of Retrophin
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of H. Lundbeck
Table Sales Revenue, Volume, Price, Cost and Margin of Mallinckrodt
Table Sales Revenue, Volume, Price, Cost and Margin of Insys Therapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of Orphelia Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Valerion Therapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of Catalyst Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Anavex Life Sciences
Table Sales Revenue, Volume, Price, Cost and Margin of Retrophin
LIST OF FIGURES
Figure Oral Market Size and CAGR 2013-2017 (Million USD)
Figure Oral Market Size and CAGR 2013-2017 (Volume)
Figure Oral Market Forecast and CAGR 2018-2025 (Million USD)
Figure Oral Market Forecast and CAGR 2018-2025 (Volume)
Figure Injection Market Size and CAGR 2013-2017 (Million USD)
Figure Injection Market Size and CAGR 2013-2017 (Volume)
Figure Injection Market Forecast and CAGR 2018-2025 (Million USD)
Figure Injection Market Forecast and CAGR 2018-2025 (Volume)
Figure Hospital Market Size and CAGR 2013-2017 (Million USD)
Figure Hospital Market Size and CAGR 2013-2017 (Volume)
Figure Hospital Market Forecast and CAGR 2018-2025 (Million USD)
Figure Hospital Market Forecast and CAGR 2018-2025 (Volume)
Figure Clinic Market Size and CAGR 2013-2017 (Million USD)
Figure Clinic Market Size and CAGR 2013-2017 (Volume)
Figure Clinic Market Forecast and CAGR 2018-2025 (Million USD)
Figure Clinic Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Infantile Spasms Therapeutics Market Size and CAGR 2013-2017 (Million USD)
Figure Global Infantile Spasms Therapeutics Market Size and CAGR 2013-2017 (Volume)
Figure Global Infantile Spasms Therapeutics Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Infantile Spasms Therapeutics Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Infantile Spasms Therapeutics Market Size and CAGR 2013-2017 (Million USD)
Figure United States Infantile Spasms Therapeutics Market Size and CAGR 2013-2017 (Volume)
Figure United States Infantile Spasms Therapeutics Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Infantile Spasms Therapeutics Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Infantile Spasms Therapeutics SWOT List
Figure Healthcare & Medical Porter's Five Forces
Figure Oral Market Size and CAGR 2013-2017 (Million USD)
Figure Oral Market Size and CAGR 2013-2017 (Volume)
Figure Oral Market Forecast and CAGR 2018-2025 (Million USD)
Figure Oral Market Forecast and CAGR 2018-2025 (Volume)
Figure Injection Market Size and CAGR 2013-2017 (Million USD)
Figure Injection Market Size and CAGR 2013-2017 (Volume)
Figure Injection Market Forecast and CAGR 2018-2025 (Million USD)
Figure Injection Market Forecast and CAGR 2018-2025 (Volume)
Figure Hospital Market Size and CAGR 2013-2017 (Million USD)
Figure Hospital Market Size and CAGR 2013-2017 (Volume)
Figure Hospital Market Forecast and CAGR 2018-2025 (Million USD)
Figure Hospital Market Forecast and CAGR 2018-2025 (Volume)
Figure Clinic Market Size and CAGR 2013-2017 (Million USD)
Figure Clinic Market Size and CAGR 2013-2017 (Volume)
Figure Clinic Market Forecast and CAGR 2018-2025 (Million USD)
Figure Clinic Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Infantile Spasms Therapeutics Market Size and CAGR 2013-2017 (Million USD)
Figure Global Infantile Spasms Therapeutics Market Size and CAGR 2013-2017 (Volume)
Figure Global Infantile Spasms Therapeutics Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Infantile Spasms Therapeutics Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Infantile Spasms Therapeutics Market Size and CAGR 2013-2017 (Million USD)
Figure United States Infantile Spasms Therapeutics Market Size and CAGR 2013-2017 (Volume)
Figure United States Infantile Spasms Therapeutics Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Infantile Spasms Therapeutics Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Infantile Spasms Therapeutics SWOT List
Figure Healthcare & Medical Porter's Five Forces
